All the Drug Class Drugs
Quinolone. Ciprofloxacin (as HCl) 3 mg/ml. EYE AND EAR DROPS (SOL.): 5 ml.
Adults and child from 1 yr:
Corneal ulc.: 2 drops every 15 mins. for
first 6 hrs., then 2 drops every 30 mins.
for rest of day. 2nd day: 2 drops hrly.
On 3rd-14th day: 2 drops every 4 hrs.
for up to 14 days.
Bact. conjunct: 1-2 drops into conjuct.
sac(s) every 2 hrs. for 2 days, then 1-2
drops every 4 hrs. for next 5 days.
Otic use: 3 to 4 drops, 2-4 /d, or more
frequently, if required.
In gen., the duration of tmt does not
exceed 5-10 ds.
For either ind. a max. duration of ther.
of 21 days is recommend.
Corneal ulc., conjunct. caused by suscep.
gram pos., gram neg. microorg. for adults
and ped. pts > 1 yr.
For local./diff. otitis externa accomp. by a
strong inflamm. react. and of which the
strains are suscept., and for the acute flare-up of a chronic otitis media. In this
case, a mucopurulent secret.
In other infect. of the ear in which
Pseudom. aerug. and/or other suscept.
strains may be suspect., it can be used
under the strict superv. of an ear specialist.
It must be understood that this is not a
routine tmt and improper use must be
avoided.
C/I: Hypersens. to the product or other
quinolones.
Quinolone. Ciprofloxacin (HCl) 250, 500, 750 mg. TABS: 10. Upper and lower respir. tract
infects: 250-750 mg 2 x dly. Upper and
lower urin. tract infects: 250-500 mg 2
x dly. Pneumococ. pneumon. and cystic
fibros. pts. with P. infects. of lower
respir. tract: 750 mg 2 x dly. Other
infects: 500-750 mg 2 x dly. For ped.
cystic fibros. pts. aged 5-17 yrs. with
acute pulm. exacerbat. assoc. with P.
aeruginosa infects: 20 mg/kg 2 x dly.
Max. dly dose: 1,500 mg.
Infects. caused by ciprofloxacin-sens.
pathogens: tmt. invas. infect. extern. ear;
tmt. acute pulm. exacerbat. of cystic
fibrosis assoc. with Pseudomonas
aeruginosa in ped. pts. aged 5-17 yrs.
C/I: Known hypersens. to ciprofloxacin or
other quinolone deriv., child. and grow.
adolesc., pregn., lact.
Quinolone. Ciprofloxacin (as lactate) 2 mg/ml. INFUS. BAGS (sol. for infus.): 1, 5, 10, 12 x
100 ml, 200 ml x 2 mg/ml. See lit.
Infects. caused by ciprofloxacin-sens.
pathogens, tmt. acute pulm. exacerbat.
of cystic fibrosis assoc. with
Pseudomonas aeruginosa in ped. pts.
aged 5-17 yrs.
C/I: Known hypersens. to ciprofloxacin
or other quinolone deriv., child. and
grow. adolesc., pregn., lact.
Quinolone. Levofloxacin (as Hemihydrate) 500 mg. TABS: 5. 1 tab 1-2 x dly for up to 14
days.
Mild to mod. infects. incl. acute sinusit.,
acute chron. bronchit., common acq.
pneumon., complicat. urin. tract infects.,
skin and soft tissue infects.
C/I: Hypersens., epilepsy, fluroquinolone
related tendon disords., pregn., lact.,
child up to 18 yrs.
Quinolone. Levofloxacin 5 mg/ml. Sol. (infus.) 10 x 50 ml; 100 ml polyolefin bags. Commun.-acquir.pneum.- 500 mg once, twice dly. Compl. UTI , pyelonephrit. 250 mg×1/d. Skin, soft tissue infec.- 250 mg mg×1/d. Pts. with renal impair. dose ajust. is needed.
Commun. acquir. pneum., Compl. UTI , pyelonephrit., Skin and soft tiss.infec.
C/I: Hypersens., hypersens. to quinolones, fluoroquinolone related tendon disords., epilepsy, pts. under 18 yrs, preg., lact.
Quinolone. Moxifloxacin 400 mg / 250 ml. INFUS. SOLN: 250 ml. See lit
Adults (>18 yrs) with community acq.
pneumon./complicat. skin/struct. infects.
caused by specif. pathogens.
C/I: Hypersens. to compon. or other
quinolones, pregn., lact., under 18 yrs.
